AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2004 NOV 3 - (NewsRx.com & NewsRx.net) -- The following is a statement from the U.S. Department of Health and Human Services (HHS) regarding Chiron flu vaccine:
"Clearly, the loss of the Chiron flu vaccine poses a serious challenge to our vaccine supply for the upcoming flu season. Chiron was to produce between 46 and 48 million doses of influenza vaccine for the United States. The department has begun pursuing contingencies for this loss of supply."
"We currently anticipate having approximately 54 million doses of influenza vaccine from Aventis and about another 1-2 million doses of FluMist nasal spray. HHS had planned for a vaccine supply of about 100 million doses this season after a demand of about 87 million doses last flu season."
"Our immediate focus will be on making sure that the supply we do have reaches those who are most vulnerable. The Centers for Disease Control and Prevention is convening its Advisory Committee on Immunization Practices to prioritize its recommendations on who should get the flu vaccine for this season based on the new vaccine ...